Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8284) 8284
Newsletter (808) 808
Newspaper Article (616) 616
Book Chapter (33) 33
Magazine Article (30) 30
Book / eBook (22) 22
Trade Publication Article (10) 10
Dissertation (8) 8
Conference Proceeding (4) 4
Web Resource (4) 4
Publication (3) 3
Reference (2) 2
Transcript (2) 2
Book Review (1) 1
Government Document (1) 1
Report (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (6908) 6908
humans (6179) 6179
life sciences & biomedicine (6113) 6113
human papillomavirus (5343) 5343
female (5143) 5143
vaccines (3543) 3543
cervical cancer (3443) 3443
papillomavirus infections (3436) 3436
immunology (3278) 3278
papillomavirus infections - prevention & control (2543) 2543
vaccination (2503) 2503
adult (2356) 2356
cancer (2095) 2095
adolescent (1934) 1934
infectious diseases (1778) 1778
oncology (1777) 1777
immunization (1749) 1749
male (1634) 1634
papillomavirus vaccines - immunology (1584) 1584
animals (1572) 1572
uterine cervical neoplasms - prevention & control (1567) 1567
biological and medical sciences (1555) 1555
medicine, research & experimental (1527) 1527
research & experimental medicine (1527) 1527
health aspects (1517) 1517
papillomavirus infections - virology (1441) 1441
uterine cervical neoplasms - virology (1440) 1440
research (1427) 1427
microbiology (1421) 1421
middle aged (1411) 1411
papillomavirus vaccines - administration & dosage (1372) 1372
young adult (1350) 1350
papillomaviruses (1315) 1315
papillomavirus infections - immunology (1270) 1270
papillomaviridae - immunology (1233) 1233
virology (1224) 1224
papillomavirus infections - epidemiology (1218) 1218
infections (1193) 1193
tumors (1161) 1161
medical research (1150) 1150
medical sciences (1130) 1130
mice (1047) 1047
hpv (1018) 1018
viruses (1008) 1008
analysis (1007) 1007
risk factors (993) 993
prevention (930) 930
allergy and immunology (910) 910
child (910) 910
papillomavirus infections - complications (906) 906
medicine (899) 899
womens health (890) 890
research article (877) 877
immunotherapy (830) 830
virus diseases (824) 824
cervix (818) 818
fundamental and applied biological sciences. psychology (804) 804
science & technology - other topics (798) 798
multidisciplinary sciences (789) 789
papillomaviridae - genetics (783) 783
public health (766) 766
medicine, experimental (744) 744
oncogene proteins, viral - immunology (729) 729
human papillomavirus 16 - immunology (719) 719
proteins (700) 700
science (696) 696
epidemiology (681) 681
aged (674) 674
studies (667) 667
deoxyribonucleic acid--dna (651) 651
antigens (648) 648
care and treatment (644) 644
papillomavirus vaccines (617) 617
viral diseases (608) 608
uterine cervical neoplasms - immunology (603) 603
vaccine (599) 599
uterine cervical neoplasms - epidemiology (597) 597
women (589) 589
mice, inbred c57bl (588) 588
prevalence (582) 582
diagnosis (579) 579
papillomavirus vaccines - therapeutic use (577) 577
medical screening (570) 570
cancer vaccines (563) 563
sexually transmitted diseases (560) 560
biotechnology & applied microbiology (555) 555
antibodies, viral - blood (538) 538
vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (525) 525
abridged index medicus (514) 514
miscellaneous (513) 513
papillomaviridae - isolation & purification (513) 513
age (511) 511
oncogene proteins, viral - genetics (511) 511
clinical trials (491) 491
female genital diseases and pregnancy complications (477) 477
applied microbiology (457) 457
dna (455) 455
immune response (455) 455
health knowledge, attitudes, practice (451) 451
genotype (446) 446
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9667) 9667
French (59) 59
Chinese (56) 56
German (48) 48
Spanish (24) 24
Japanese (20) 20
Portuguese (17) 17
Russian (8) 8
Dutch (7) 7
Italian (7) 7
Czech (5) 5
Polish (5) 5
Finnish (3) 3
Hebrew (3) 3
Hungarian (3) 3
Swedish (3) 3
Bulgarian (2) 2
Croatian (1) 1
Icelandic (1) 1
Norwegian (1) 1
Persian (1) 1
Romanian (1) 1
Serbian (1) 1
Slovenian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
by Trimble, Cornelia L, Prof and Morrow, Matthew P, PhD and Kraynyak, Kimberly A, PhD and Shen, Xuefei, PhD and Dallas, Michael, PhD and Yan, Jian, PhD and Edwards, Lance, MD and Parker, R Lamar, MD and Denny, Lynette, MD and Giffear, Mary, BS and Brown, Ami Shah, PhD and Marcozzi-Pierce, Kathleen, MA and Shah, Divya, MS and Slager, Anna M, MS and Sylvester, Albert J, MS and Khan, Amir, PhD and Broderick, Kate E, PhD and Juba, Robert J, MSCEP and Herring, Timothy A, MPH and Boyer, Jean, PhD and Lee, Jessica, MPH and Sardesai, Niranjan Y, PhD and Weiner, David B, Prof and Bagarazzi, Mark L, MD
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 386, Issue 10008, pp. 2078 - 2088
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Human papillomavirus 18 - immunology | Humans | Papillomavirus E7 Proteins - immunology | Vaccines, DNA - immunology | Cervical Intraepithelial Neoplasia - drug therapy | Human papillomavirus 16 - immunology | Papillomavirus E7 Proteins - genetics | Young Adult | Cancer Vaccines - therapeutic use | Adult | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | DNA-Binding Proteins - immunology | Papillomavirus Vaccines - therapeutic use | Double-Blind Method | Repressor Proteins - genetics | Treatment Outcome | Uterine Cervical Neoplasms - drug therapy | Vaccines, DNA - therapeutic use | DNA-Binding Proteins - genetics | Cervical Intraepithelial Neoplasia - virology | Cancer Vaccines - immunology | Repressor Proteins - immunology | Papillomavirus Infections - drug therapy | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Oncogene Proteins, Viral - immunology | Human papillomavirus 16 - genetics | Proteins | Cervix dysplasia | DNA | Clinical trials | Product development | Vaccines | Health aspects | Papillomavirus infections | Medical research | Analysis | Medicine, Experimental | Human papillomavirus | Immunization | Womens health | Immunotherapy | Genomes | Cervical cancer | Deoxyribonucleic acid--DNA | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells
by Baghban Rahimi, Sanaz and Baghban Rahimi, Sanaz and Mohebbi, Alireza and Mohebbi, Alireza and Vakilzadeh, Gelareh and Vakilzadeh, Gelareh and Biglari, Peyvand and Biglari, Peyvand and Razeghi Jahromi, Soodeh and Razeghi Jahromi, Soodeh and Mohebi, Seyed Reza and Mohebi, Seyed Reza and Shirian, Sadegh and Shirian, Sadegh and Gorji, Ali and Gorji, Ali and Ghaemi, Amir and Ghaemi, Amir
Archives of virology, ISSN 0304-8608, 3/2018, Volume 163, Issue 3, pp. 587 - 597
Medical Microbiology | Infectious Diseases | Biomedicine | Virology | Life Sciences & Biomedicine | Science & Technology | Vaccines, DNA - genetics | Adjuvants, Immunologic - administration & dosage | Papillomavirus Vaccines - genetics | Epithelial Cells - drug effects | Tumor Necrosis Factor-alpha - genetics | Vaccination | Papillomavirus E7 Proteins - immunology | Vaccines, DNA - immunology | Human papillomavirus 16 - drug effects | Human papillomavirus 16 - immunology | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Vascular Endothelial Growth Factor A - genetics | Vaccines, DNA - administration & dosage | Melatonin - administration & dosage | Papillomavirus E7 Proteins - genetics | Cancer Vaccines - genetics | T-Lymphocytes, Cytotoxic - drug effects | Tumor Necrosis Factor-alpha - immunology | Melatonin - immunology | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Interferon-gamma - genetics | Interleukin-4 - genetics | Papillomavirus Vaccines - administration & dosage | T-Lymphocytes, Cytotoxic - immunology | Cancer Vaccines - administration & dosage | Mice, Inbred C57BL | Plasmids - immunology | Gene Expression Regulation | Vascular Endothelial Growth Factor A - immunology | Papillomavirus Infections - mortality | Tumor Burden | Cancer Vaccines - immunology | Interleukin-4 - immunology | Animals | Lymphocyte Activation - drug effects | Papillomavirus Infections - prevention & control | Epithelial Cells - immunology | Interferon-gamma - immunology | Plasmids - chemistry | Survival Analysis | Cell Line, Tumor | Papillomavirus Vaccines - immunology | Cell Proliferation - drug effects | Mice | Human papillomavirus 16 - genetics | Plasmids - administration & dosage | Melatonin | Endothelial growth factors | Analysis | DNA | Resveratrol | Genetic research | Vaccines | T cells | Health aspects | Papillomavirus infections | Cell proliferation | Cell survival | CD8 antigen | Cytotoxicity | Lymphocytes T | DNA vaccines | Tumor necrosis factor-α | Cancer vaccines | Human papillomavirus | Interleukin 4 | γ-Interferon | Combined vaccines | Interleukin 10 | Antitumor activity | Interferon | Lactic acid | Vascular endothelial growth factor | Enzyme-linked immunosorbent assay | Deoxyribonucleic acid--DNA | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Major findings and recent advances in virus–like particle (VLP)-based vaccines
by Mohsen, Mona O and Zha, Lisha and Cabral-Miranda, Gustavo and Bachmann, Martin F
Seminars in immunology, ISSN 1044-5323, 12/2017, Volume 34, Issue C, pp. 123 - 132
Virus | Vaccine | Virus-like particles | Innate & adaptive immune response | Life Sciences & Biomedicine | Immunology | Science & Technology | Adaptive Immunity | Virus Diseases - immunology | Humans | Immunity, Innate | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Vaccines, Virus-Like Particle - chemistry | Papillomaviridae - immunology | Animals | Capsid Proteins | Hepatitis B Vaccines | Vaccines, Virus-Like Particle - immunology | Hepatitis B virus - immunology | Viral Vaccines - immunology | Papillomavirus Vaccines | Immunoglobulin M | Hepatitis | Immune response | Malaria | Dendritic cells | Esters | Amino acids | Interferon | Vaccines | Glutamate | Papillomavirus infections | Immunity | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Developments in L2-based human papillomavirus (HPV) vaccines
by Schellenbacher, Christina and Roden, Richard B.S and Kirnbauer, Reinhard
Virus research, ISSN 0168-1702, 03/2017, Volume 231, pp. 166 - 175
HPV infection and disease | Human papillomavirus (HPV) vaccine | Squamous cell cancer (SCC) | Cutaneous and anogenital warts (condylomata) | Minor capsid protein (L2) | Cervical cancer (CxCa) | Life Sciences & Biomedicine | Science & Technology | Virology | Immunogenicity, Vaccine | Recombinant Fusion Proteins - immunology | Head and Neck Neoplasms - virology | Oncogene Proteins, Viral - chemistry | Papillomaviridae - drug effects | Humans | Vaccination | Cross Protection | Papillomavirus Vaccines - biosynthesis | Uterine Cervical Neoplasms - pathology | Epitopes - immunology | Papillomavirus Infections - pathology | Papillomaviridae - immunology | Capsid Proteins - chemistry | Vaccines, Virus-Like Particle | Capsid Proteins - immunology | Papillomavirus Infections - immunology | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Papillomavirus Vaccines - administration & dosage | Antibodies, Viral - biosynthesis | Head and Neck Neoplasms - prevention & control | Papillomaviridae - growth & development | Cancer Vaccines - administration & dosage | Cancer Vaccines - biosynthesis | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Vaccines, Subunit - immunology | Recombinant Fusion Proteins - chemistry | Head and Neck Neoplasms - pathology | Papillomaviridae - pathogenicity | Cancer Vaccines - immunology | Head and Neck Neoplasms - immunology | Animals | Vaccines, Subunit - biosynthesis | Antibodies, Neutralizing - biosynthesis | Papillomavirus Infections - prevention & control | Vaccines, Subunit - administration & dosage | Immunity, Humoral - drug effects | Recombinant Fusion Proteins - genetics | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Epitopes - chemistry | Mice | Oncogene Proteins, Viral - immunology | Capsid Proteins - genetics | Prevention | Vaccines | Viral proteins | Health aspects | Papillomavirus infections | Wildlife conservation | Peptides | Development and progression | Papillomaviruses | Warts | Sexually transmitted diseases | Analysis | Skin | Cervical cancer | Antigenic determinants | Index Medicus | Human Papillomavirus (HPV) Vaccine | Cervical Cancer (CxCa) | Minor Capsid Protein (L2) | Squamous Cell Cancer (SCC) | cutaneous and anogenital warts (condylomata)
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Quadrivalent Human Papillomavirus (HPV) Vaccine Induces HPV-Specific Antibodies in the Oral Cavity: Results from the Mid-Adult Male Vaccine Trial
by Pinto, Ligia A and Kemp, Troy J and Torres, B. Nelson and Isaacs-Soriano, Kimberly and Ingles, Donna and Abrahamsen, Martha and Pan, Yuanji and Lazcano-Ponce, Eduardo and Salmeron, Jorge and Giuliano, Anna R
The Journal of infectious diseases, ISSN 0022-1899, 10/2016, Volume 214, Issue 8, pp. 1276 - 1283
Serum | Mouthwash | HPV vaccine | Males | Saliva | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Saliva - immunology | Human papillomavirus 18 - immunology | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - immunology | Humans | Middle Aged | Mouth - immunology | Male | Human papillomavirus 16 - immunology | Florida | Antibodies, Neutralizing - immunology | Vaccination - methods | Immunoglobulin G - immunology | Papillomavirus Infections - prevention & control | Papillomavirus Infections - immunology | Adult | Antibodies, Viral - immunology | Mexico | Papillomavirus Vaccines - immunology | Throat cancer | Papillomavirus infections | Research | Index Medicus | Abridged Index Medicus | saliva | Major and Brief Reports | males | mouthwash | serum
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
by Del Giudice, Giuseppe and Rappuoli, Rino and Didierlaurent, Arnaud M
Seminars in immunology, ISSN 1044-5323, 10/2018, Volume 39, Issue C, pp. 14 - 21
Herpes zoster | Human papillomavirus | Immunostimulation | Pandemic influenza | Adjuvants | Innate immunity | Efficacy | Seasonal influenza | Vaccines | Hepatitis B virus | Antibody response | Cellular response | Life Sciences & Biomedicine | Immunology | Science & Technology | Herpes Zoster - prevention & control | Immunogenicity, Vaccine | Adjuvants, Immunologic - pharmacology | Polysorbates - chemistry | Liposomes - administration & dosage | Humans | Th2 Cells - immunology | Th1 Cells - immunology | Th2 Cells - drug effects | Th2 Cells - microbiology | Immunity, Cellular - drug effects | Polysorbates - pharmacology | Adjuvants, Immunologic - chemistry | Papillomavirus Infections - immunology | Influenza, Human - virology | Papillomavirus Infections - virology | alpha-Tocopherol - pharmacology | Liposomes - immunology | alpha-Tocopherol - chemistry | Herpes Zoster - immunology | Squalene - chemistry | Th1 Cells - drug effects | Viral Vaccines - administration & dosage | Liposomes - chemistry | Th1 Cells - microbiology | Animals | Squalene - pharmacology | Herpes Zoster - virology | Papillomavirus Infections - prevention & control | Viral Vaccines - chemistry | Immunity, Humoral - drug effects | Aged | Influenza, Human - prevention & control | Viral Vaccines - immunology | Drug Combinations | Influenza, Human - immunology | Influenza vaccines | Antigens | Analysis | Influenza | Vaccination | Lipids | Health aspects | Papillomavirus infections | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies
by Kreimer, Aimée R and Herrero, Rolando and Sampson, Joshua N and Porras, Carolina and Lowy, Douglas R and Schiller, John T and Schiffman, Mark and Rodriguez, Ana Cecilia and Chanock, Stephen and Jimenez, Silvia and Schussler, John and Gail, Mitchell H and Safaeian, Mahboobeh and Kemp, Troy J and Cortes, Bernal and Pinto, Ligia A and Hildesheim, Allan and Gonzalez, Paula and for the Costa Rica HPV Vaccine Trial (CVT) Group and Costa Rica HPV Vaccine Trial CVT and Costa Rica HPV Vaccine Trial (CVT) Group
Vaccine, ISSN 0264-410X, 08/2018, Volume 36, Issue 32, pp. 4774 - 4782
Prevention | Human papillomavirus | HPV-driven cancers | Reduced dose | Vaccine | Cervical cancer | HPV | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Mass Vaccination | Human papillomavirus 18 - immunology | Papillomavirus Vaccines - therapeutic use | Humans | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - epidemiology | Uterine Cervical Neoplasms - prevention & control | Clinical Trials as Topic | Human papillomavirus 16 - immunology | Papillomavirus Infections - therapy | Serum - immunology | Time Factors | Papillomavirus Infections - prevention & control | Adolescent | Costa Rica - epidemiology | Adult | Antibodies, Viral - immunology | Female | Immunization Schedule | Papillomavirus Vaccines - administration & dosage | Uterine Cervical Neoplasms - therapy | Analysis | Oncology, Experimental | Vaccination | Clinical trials | Vaccines | Research | Papillomavirus infections | Cancer | Laboratories | Durability | Infections | Medical screening | Antibody response | Studies | Womens health | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights